M

MannKind Corp

D
MNKD
USD
-0.04
(-0.5376%)
Market Closed
111,417.00
Volume
0.08
EPS
-
Div Yield
139.800
P/E
2,034,963,273.80
Market Cap
Today
1.7882%
1 Week
4.668%
1 Month
16.719%
6 Months
64.994%
12 Months
95.509%
Year To Date
103.018%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ABBV
ABBV
-0.78
(-0.3876%)
USD
A
ACRS
0.185
(8.1498%)
USD
A
ACAD
1.42
(8.993%)
USD
A
ADAP
-0.0586
(-7.0585%)
USD
A
AGIO
3.39
(6.5698%)
USD
ALNY
ALNY
4.735
(1.7707%)
USD
A
AMRN
-0.0142
(-2.3966%)
USD
AMGN
AMGN
0.28
(0.087%)
USD
A
ASMB
0.155
(0.9118%)
USD
A
ATNM
-0.05
(-2.6738%)
USD
B
BHC
-0.26
(-2.6832%)
USD
BMY
BMY
-0.57
(-1.0313%)
USD
C
CARA
0.0317
(9.8356%)
USD
C
CGEN
0.108
(6.3084%)
USD
C
CRBP
-0.36
(-1.9027%)
USD
C
CRIS
0.18
(4.2857%)
USD
C
CRSP
1.15
(2.2656%)
USD
C
CTIC
0.11
(2.5404%)
USD
D
DVAX
-0.29
(-2.3577%)
USD
E
EXEL
0.28
(0.7883%)
USD
F
FATE
-0.24
(-8.6022%)
USD
F
FGEN
0.0027
(0.8727%)
USD
F
FOLD
-0.98
(-8.2077%)
USD
G
GERN
0.005
(0.1168%)
USD
G
GLPG
0.695
(2.5962%)
USD
I
INCY
1.47
(1.8173%)
USD
I
IOVA
0.13
(1.0704%)
USD
I
ITCI
1.16
(1.2981%)
USD
K
KALA
-0.06
(-0.8696%)
USD
K
KPTI
-0.0043
(-0.4857%)
USD
M
MRTX
(%)
USD
N
NKTR
-0.015
(-1.0791%)
USD
N
NVCR
1.015
(6.0998%)
USD
O
OMER
-0.04
(-0.8801%)
USD
O
ORMP
0.035
(1.4957%)
USD
PFE
PFE
0.105
(0.3839%)
USD
P
PRTA
-0.16
(-0.907%)
USD
Q
QURE
0.26
(3.6212%)
USD
R
RIGL
0.38
(2.5216%)
USD
S
SGEN
(%)
USD
S
SRRK
-0.64
(-2.1614%)
USD
T
TBPH
0.515
(6.2349%)
USD
T
TGTX
0.7
(2.5735%)
USD
V
VERU
-0.01
(-1.3514%)
USD
V
VSTM
-0.27
(-6.9858%)
USD
X
XNCR
0.52
(2.2907%)
USD

Title:
MannKind Corp

Sector:
Healthcare
Industry:
Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Do you need help or have a question?
Contact Us